• Behandling af duodenale og gastriske ulcera • Behandling af refluksøsofagitis • Profylakse af refluksøsofagitis • Udryddelse af Helicobacter pylori (H. pylori) kombineret med passende antibiotika, til behandling af H. pylori- relaterede ulcera • Behandling af NSAID- relaterede godartede gastriske og duodenale ulcera hos patienter, der kræver fortsat behandling med NSAID • Profylakse af NSAID- relaterede gastriske og duodenale ulcera hos udsatte patienter (se punkt 4. 2), der kræver fortsat behandling • Symptomatisk gastroøsofageal reflukssygdom • Zollinger- Ellisons syndrom.
• Treatment of duodenal and gastric ulcer • Treatment of reflux oesophagitis • Prophylaxis of reflux oesophagitis • Eradication of Helicobacter pylori (H. pylori) concurrently given with appropriate antibiotic therapy for treatment of H. pylori associated ulcers • Treatment of NSAID-associated benign gastric and duodenal ulcers in patients requiring continued NSAID treatment • Prophylaxis of NSAID-associated gastric ulcers and duodenal ulcers in patients at risk (see section 4.2) requiring continued therapy • Symptomatic gastroesophageal reflux disease • Zollinger-Ellison syndrome.